MONDAY, May 6, 2024 (HealthDay News) — A new combination therapy appears to boost the response rate for liver cancer patients receiving immunotherapy, according to results from a phase 2 clinical trial. The combo therapy involves bavituximab, a drug that neutralizes a fatty substance called phosphatidylserine that cancer cells useContinue Reading

THURSDAY, May 2, 2024 (HealthDay News) — An experimental cancer vaccine can quickly reprogram a person’s immune system to attack glioblastoma, the most aggressive and lethal form of brain cancer, a small, preliminary study has found. The cancer vaccine is based on mRNA technology similar to that used in COVIDContinue Reading

MONDAY, April 29, 2024 (HealthDay News) — Britain’s King Charles III is back to resuming his royal duties following treatment for cancer, Buckingham Palace announced Friday. “His Majesty The King will shortly return to public-facing duties after a period of treatment and recuperation following his recent cancer diagnosis,” the PalaceContinue Reading